DNA Microarray Market Size to Reach USD 8,677.7 Million in 2028, Noted Reports and Data

Advancements in DNA microarray techniques, growing prevalence of various diseases, and increasing need for rapid and accurate diagnosis are key factors fueling global market growth

The global DNA microarray market size is expected to reach USD 8677.7 Million in 2028 and register a CAGR of 12.6%, according to the latest report by Reports and Data. Rising prevalence of cancer, growing adoption of DNA microarray technology in various applications such as cancer research, genetic disease diagnosis, and personalized medicine are key factors driving global market revenue growth. 

DNA microarray is a laboratory tool used for measuring patterns of several genes simultaneously. It is a collection of microscopic DNA spots that are attached to a solid surface that aid in measuring expression of large number of genes at once. These microarrays are extensively used in gene expression, early-stage cancer detection, and drug discovery. The DNA microarray market is gaining significant traction in recent years. Increasing applications of DNA microarray technique, rapid growth in genomics and medical sector, rising prevalence of several chronic diseases and growing adoption of microarray techniques to detect various infectious diseases is boosting demand for DNA microarray across the world. Factors such as growing adoption of genetic testing, rising research and development activities in pharmaceutical and biotechnology sector, and rapid developments in healthcare infrastructure and facilities are boosting market growth. Moreover, increasing investments by leading players to develop more efficient and enhanced DNA microarrays is expected to boost growth of the global DNA microarray market during the forecast period. In addition, growing focus on R&D in cancer is projected to open lucrative opportunities for key players going ahead. 

However, high costs associated with sequencing and lack of skilled professionals to carry out these processes are expected to hamper global market revenue growth throughout the forecast period. 

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/288

Some Key Highlights from the Report:

  • The Oligonucleotide DNA Microarrays (oDNA) segment is expected to register highest revenue CAGR throughout the forecast period. The oDNA microarrays are preferred over cDNA as they offer more hybridization specificity and are thus used for analyzing gene expression and single nucleotide polymorphisms.  
  • Among the application segment, the drug discovery segment is projected to account for fastest revenue growth over the forecast period, owing to increasing prevalence of infectious diseases, cancer, and growing demand for DNA microarrays in drug discovery processes including disease pathway identification, compound screening, and clinical trials. 
  • The academic & research institutes segment is projected to account for significant  revenue growth during the forecast period owing to extensive use of DNA microarray in ongoing research and development activities and government funds for various research projects. 
  • North America is expected to account for largest revenue share in the global DNA microarray market over the forecast period. Technological advancements in genomics, high prevalence of age-related chronic diseases, and access to modern research facilities are key factors contributing to global market revenue growth. In addition, high investments in research and development activities and presence of key players are fueling market growth. 
  • The market in Asia Pacific is expected to register fastest revenue throughout the forecast period. Increasing investments in genomic research, high prevalence of diseases, and rising awareness about genetic testing are boosting market revenue growth. 
  • Illumina, Affymetrix, Biometrix Technology, Arrayit, Sengenics, WaferGen, Applied Microarrays, Savyon Diagnostics, Scienion AG, Gyros AB, Agilent Technologies, Roche NimbleGen Inc., ProteoGenix, NextGen Sciences, Discerna, and Luminex Corporation are some leading companies operating in the global DNA array market. 

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/288

For this study, Reports and Data has segmented the global DNA microarray market based on type, application, end-use, and region:

Type Outlook (Revenue in USD Million, 2018–2028)

  • Complementary DNA Microarrays (cDNA) 
  • Oligonucleotide DNA Microarrays (oDNA)

Application Outlook (Revenue in USD Million, 2018–2028)

  • Gene Expression Analysis
  • Genotyping
  • Genome Cytogenetics
  • Drug Delivery
  • Other

End-Use Outlook (Revenue, USD Million, 2018 - 2028)

  • Diagnostic Centers
  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Industries 
  • Academic & Research Institutes
  • Others

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/288

Regional Outlook (Revenue, USD Million, 2018 - 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

MicroRNA (miRNA) Market Analysis, By Product Type (Instruments, Kits, Reagents & Consumables), By Tools Type (qRT-PCR, Biomarkers), By Services Type (Microarray Services, Functional Studies Services), By Application Type (Cancer, Infectious Diseases), by End Use Type (Academic & Research Institutes, Biopharmaceutical Companies), Forecasts to 2026

Biochip Market Size, Trends & Analysis, By Product (DNA Chip, Lab-on-chip, Protein Chip, Others), By Technology (Microfluidics And Microarray), By Substrate Materials (Glass, Polymers, Silicon, Others), By Application (Genomics, Proteomics, Drug Discovery & Developments, In Vitro Diagnostics, Disease Diagnostics, Agriculture), By End-User (Pharmaceutical & Biotechnology Company, Academic & Research Institute, Hospitals & Diagnostic Centers, Others), By Region Forecast To 2027

Blood Culture Tests Market Analysis, By Application (Bacteraemia, Fungemia) By Product (Consumables, Instrument) By Technology (Microarray, PCR, Proteomic) By End Use (Hospital Laboratories, Reference Laboratories), Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-dna-microarray-market

Back to news